Raised natriuretic peptides, Bigendothelin- 1 and improved beta-cell function in type 2 diabetic males with hyperuricaemia

Diabetes and Vascular Disease Research

Volumn 6, Issue 3, 2009, Pages 190-193

  Hermans, Michel P ^a,b   Ahn, Sylvie A ^a   Rousseau, Michel F ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Beta cell function; Diabetes; Metabolic syndrome; Neurohormones; Uric acid

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIG ENDOTHELIN 1; BRAIN NATRIURETIC PEPTIDE; GLUCOSE; NEUROHORMONE; URIC ACID; UROTENSIN II; BIOLOGICAL MARKER; ENDOTHELIN 1; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; REPERFUSION INJURY; VASCULAR DISEASE; AGED; BLOOD; GLUCOSE BLOOD LEVEL; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; UPREGULATION;

AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENDOTHELIN-1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERURICEMIA; INSULIN; INSULIN-SECRETING CELLS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; UP-REGULATION; URIC ACID;

EID: 77950676361     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164109336689     Document Type: Article

References (10)

1. Feig, DI, Kang, DH, Johnson, RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359: 1811-21.
2. Kanai, Y (2008) Molecular mechanisms of urate transport in renal tubules: Localization and function of urate transporters Nippon Rinsho 66: 659-66.
3. Nieto, FJ, Iribarren, C, Gross, MD, Comstock, GW, Cutler, RG (2000) Uric acid and serum antioxidant capacity: A reaction to atherosclerosis? Atherosclerosis 148: 131-9.
4. Johnson, RJ, Gaucher, EA, Sautin, YY, Henderson, GN, Angerhofer, AJ, Benner, SA (2008) The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease. Med Hypotheses 71: 22-31.
5. Munoko, TN, Hermans, MP (2008) Phenotypic characterization of first generation Maghrebian migrants with type 2 diabetes: A gender-based comparison with a reference North-Caucasian Belgian cohort. Diabetes Metab Syndr Clin Res Rev 2: 115-24. (Pubitemid 351622630)
6. Cheung, K, Tzameli, I, Pissios, P, Rovira, I, Gavrilova, O, Ohtsubo, T, et al. (2007) Xanthine oxidoreductase is a regulator of adipogenesis and PPAR? activity. Cell Metab 5: 115-28. (Pubitemid 46187493)
7. Sautin, YY, Nakagawa, T, Zharikov, S, Johnson, RJ (2007) Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293: C584-96. (Pubitemid 47235197)
8. Gruson, D, Rousseau, MF, Ahn, SA, van Linden, F, Ketelslegers, JM (2006) Circulating urotensin II levels in moderate to severe congestive heart failure: Its relations with myocardial function and well established neurohormonal markers. Peptides 27: 1527-31.
9. Lafontan, M, Moro, C, Berlan, M, Crampes, F, Sengenes, C, Galitzky, J (2008) Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 19: 130-7. (Pubitemid 351608304)
10. Hermans, MP, Ahn, SA, Gruson, D, Rousseau, MF (2007) The metabolic syndrome phenotype is associated with raised circulating Big endothelin-1 independently of coronary artery disease in type 2 diabetes. Diabetes Metab Syndr Clin Res Rev 1: 229-37. (Pubitemid 47629713)